Cargando…

Regenerative therapy by fusion of medicine and engineering: First-in-human clinical trials with induced pluripotent stem cells and cell sheet technology: A report of the Symposium of Regenerative Medicine for Patients

The Symposium of Regenerative Medicine for Patients, organized by the Japanese Society for Regenerative Medicine, was held on 28 September 2014 in Tokyo, Japan. The event provided an overview of the important areas of cell-based medicine, and highlighted the first-in-human clinical trial of induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Okano, Teruo, Sawa, Yoshiki, Barber, Emma, Umezawa, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581764/
https://www.ncbi.nlm.nih.gov/pubmed/31245453
http://dx.doi.org/10.1016/j.reth.2015.07.002
_version_ 1783428208127901696
author Okano, Teruo
Sawa, Yoshiki
Barber, Emma
Umezawa, Akihiro
author_facet Okano, Teruo
Sawa, Yoshiki
Barber, Emma
Umezawa, Akihiro
author_sort Okano, Teruo
collection PubMed
description The Symposium of Regenerative Medicine for Patients, organized by the Japanese Society for Regenerative Medicine, was held on 28 September 2014 in Tokyo, Japan. The event provided an overview of the important areas of cell-based medicine, and highlighted the first-in-human clinical trial of induced pluripotent stem cell (iPSC)-derived products. Recent advances in regenerative medicine were also discussed, especially regarding the use of somatic cells such as chondrocytes, skeletal myocytes and cardiomyocytes under both the Act on the Safety of Regenerative Medicine, and the Pharmaceuticals, Medical Devices and Other Therapeutic Products Act.
format Online
Article
Text
id pubmed-6581764
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Japanese Society for Regenerative Medicine
record_format MEDLINE/PubMed
spelling pubmed-65817642019-06-26 Regenerative therapy by fusion of medicine and engineering: First-in-human clinical trials with induced pluripotent stem cells and cell sheet technology: A report of the Symposium of Regenerative Medicine for Patients Okano, Teruo Sawa, Yoshiki Barber, Emma Umezawa, Akihiro Regen Ther Forum Report The Symposium of Regenerative Medicine for Patients, organized by the Japanese Society for Regenerative Medicine, was held on 28 September 2014 in Tokyo, Japan. The event provided an overview of the important areas of cell-based medicine, and highlighted the first-in-human clinical trial of induced pluripotent stem cell (iPSC)-derived products. Recent advances in regenerative medicine were also discussed, especially regarding the use of somatic cells such as chondrocytes, skeletal myocytes and cardiomyocytes under both the Act on the Safety of Regenerative Medicine, and the Pharmaceuticals, Medical Devices and Other Therapeutic Products Act. Japanese Society for Regenerative Medicine 2015-10-02 /pmc/articles/PMC6581764/ /pubmed/31245453 http://dx.doi.org/10.1016/j.reth.2015.07.002 Text en © 2015, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Forum Report
Okano, Teruo
Sawa, Yoshiki
Barber, Emma
Umezawa, Akihiro
Regenerative therapy by fusion of medicine and engineering: First-in-human clinical trials with induced pluripotent stem cells and cell sheet technology: A report of the Symposium of Regenerative Medicine for Patients
title Regenerative therapy by fusion of medicine and engineering: First-in-human clinical trials with induced pluripotent stem cells and cell sheet technology: A report of the Symposium of Regenerative Medicine for Patients
title_full Regenerative therapy by fusion of medicine and engineering: First-in-human clinical trials with induced pluripotent stem cells and cell sheet technology: A report of the Symposium of Regenerative Medicine for Patients
title_fullStr Regenerative therapy by fusion of medicine and engineering: First-in-human clinical trials with induced pluripotent stem cells and cell sheet technology: A report of the Symposium of Regenerative Medicine for Patients
title_full_unstemmed Regenerative therapy by fusion of medicine and engineering: First-in-human clinical trials with induced pluripotent stem cells and cell sheet technology: A report of the Symposium of Regenerative Medicine for Patients
title_short Regenerative therapy by fusion of medicine and engineering: First-in-human clinical trials with induced pluripotent stem cells and cell sheet technology: A report of the Symposium of Regenerative Medicine for Patients
title_sort regenerative therapy by fusion of medicine and engineering: first-in-human clinical trials with induced pluripotent stem cells and cell sheet technology: a report of the symposium of regenerative medicine for patients
topic Forum Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581764/
https://www.ncbi.nlm.nih.gov/pubmed/31245453
http://dx.doi.org/10.1016/j.reth.2015.07.002
work_keys_str_mv AT okanoteruo regenerativetherapybyfusionofmedicineandengineeringfirstinhumanclinicaltrialswithinducedpluripotentstemcellsandcellsheettechnologyareportofthesymposiumofregenerativemedicineforpatients
AT sawayoshiki regenerativetherapybyfusionofmedicineandengineeringfirstinhumanclinicaltrialswithinducedpluripotentstemcellsandcellsheettechnologyareportofthesymposiumofregenerativemedicineforpatients
AT barberemma regenerativetherapybyfusionofmedicineandengineeringfirstinhumanclinicaltrialswithinducedpluripotentstemcellsandcellsheettechnologyareportofthesymposiumofregenerativemedicineforpatients
AT umezawaakihiro regenerativetherapybyfusionofmedicineandengineeringfirstinhumanclinicaltrialswithinducedpluripotentstemcellsandcellsheettechnologyareportofthesymposiumofregenerativemedicineforpatients